Dietary Supplements in Cardiovascular and Metabolic Diseases

Bruno Trimarco,Gaetano Santulli

DOI: https://doi.org/10.3390/nu16101418

IF: 5.9

2024-05-09

Nutrients

Abstract:Recent research has sparked increasing interest in the effects of dietary supplements on cardiovascular and metabolic disorders [...]

nutrition & dietetics

What problem does this paper attempt to address?

Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes

Matteo Nardin,Monica Verdoia,Simone Nardin,Davide Cao,Mauro Chiarito,Elvin Kedhi,Gennaro Galasso,Gianluigi Condorelli,Giuseppe De Luca

DOI: https://doi.org/10.3390/biomedicines12040768

IF: 4.757

2024-03-31

Biomedicines

Abstract:Vitamin D is rightly recognized as an essential key factor in the regulation of calcium and phosphate homeostasis, affecting primary adequate bone mineralization. In the last decades, a more complex and wider role of vitamin D has been postulated and demonstrated. Cardiovascular diseases have been found to be strongly related to vitamin D levels, especially to its deficiency. Pre-clinical studies have suggested a direct role of vitamin D in the regulation of several pathophysiological pathways, such as endothelial dysfunction and platelet aggregation; moreover, observational data have confirmed the relationship with different conditions, including coronary artery disease, heart failure, and hypertension. Despite the significant evidence available so far, most clinical trials have failed to prove any positive impact of vitamin D supplements on cardiovascular outcomes. This discrepancy indicates the need for further information and knowledge about vitamin D metabolism and its effect on the cardiovascular system, in order to identify those patients who would benefit from vitamin D supplementation.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease

Angela Albarosa Rivellese,Paola Ciciola,Giuseppina Costabile,Claudia Vetrani,Marilena Vitale

DOI: https://doi.org/10.1007/s40292-019-00309-5

2019-02-27

Abstract:Cardiovascular diseases (CVDs) are the main causes of mortality and disability worldwide. Although the initial therapeutic approach to improve the main cardiovascular (CV) risk factors is based on nonpharmacological measures, mainly lifestyle modifications, compliance to recommendations is often poor and inadequate. Therefore, in recent years the use of several nutraceuticals, i.e., nutrients and/or bioactive compounds of plant or microbial origin with potentially healthful effects, has become widespread. However, to date, the scientific data on the possible benefits of the use of nutraceuticals are still inconclusive, due to the absence of adequately controlled intervention studies at least for some of them. Against this background, the scientific evidence derived from controlled intervention studies in relation to the effects of some nutraceuticals (i.e. fiber, phytosterols, soy products, red yeast rice, polyphenols and berberine) on the main CV risk factors (body weight, blood pressure, blood glucose levels and plasma lipids) in humans will be reviewed.
Recent advances in precision nutrition and cardiometabolic diseases

Miguel A Martínez-González,Francisco J Planes,Miguel Ruiz-Canela,Estefanía Toledo,Ramón Estruch,Jordi Salas-Salvadó,Rafael Valdés-Más,Pedro Mena,Olga Castañer,Montse Fitó,Clary Clish,Rikard Landberg,Clemens Wittenbecher,Liming Liang,Marta Guasch-Ferré,Rosa M Lamuela-Raventós,Dong D Wang,Nita Forouhi,Cristina Razquin,Frank B Hu

DOI: https://doi.org/10.1016/j.rec.2024.09.003

2024-09-30

Abstract:A growing body of research on nutrition omics has led to recent advances in cardiovascular disease epidemiology and prevention. Within the PREDIMED trial, significant associations between diet-related metabolites and cardiovascular disease were identified, which were subsequently replicated in independent cohorts. Some notable metabolites identified include plasma levels of ceramides, acyl-carnitines, branched-chain amino acids, tryptophan, urea cycle pathways, and the lipidome. These metabolites and their related pathways have been associated with incidence of both cardiovascular disease and type 2 diabetes. Future directions in precision nutrition research include: a) developing more robust multimetabolomic scores to predict long-term risk of cardiovascular disease and mortality; b) incorporating more diverse populations and a broader range of dietary patterns; and c) conducting more translational research to bridge the gap between precision nutrition studies and clinical applications.
Beneficial Effects of Spirulina Supplementation in the Management of Cardiovascular Diseases

Valeria Prete,Angela Carmelita Abate,Paola Di Pietro,Massimiliano De Lucia,Carmine Vecchione,Albino Carrizzo

DOI: https://doi.org/10.3390/nu16050642

IF: 5.9

2024-02-26

Nutrients

Abstract:In recent decades, as a result of rising mortality rates due to cardiovascular diseases (CVDs), there has been a growing urgency to find alternative approaches to conventional pharmaceutical treatment to prevent the onset of chronic diseases. Arthrospira platensis, commonly known as Spirulina, is a blue-green cyanobacterium, classified as a "superfood", used worldwide as a nutraceutical food supplement due to its remarkable nutritional value, lack of toxicity, and therapeutic effects. Several scientific studies have evaluated the cardioprotective role of Spirulina. This article presents a comprehensive review of the therapeutic benefits of Spirulina in improving cardio- and cerebrovascular health. It focuses on the latest experimental and clinical findings to evaluate its antihypertensive, antidiabetic, and antihyperlipidemic properties. The objective is to highlight its potential in preventing and managing risk factors associated with cardiovascular disease (CVD).

nutrition & dietetics
Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship

A. Di Giorgio,L. Santoro,A. Nesci,A. Santoliquido,Alessia D'Alessandro,Vittorio Ruggieri,A. Gasbarrini,Claudia Carnuccio,F. Ponziani

DOI: https://doi.org/10.3390/ijms24109087

IF: 5.6

2023-05-01

International Journal of Molecular Sciences

Abstract:Several studies in recent years have demonstrated that gut microbiota–host interactions play an important role in human health and disease, including inflammatory and cardiovascular diseases. Dysbiosis has been linked to not only well-known inflammatory diseases, such as inflammatory bowel diseases, rheumatoid arthritis, and systemic lupus erythematous, but also to cardiovascular risk factors, such as atherosclerosis, hypertension, heart failure, chronic kidney disease, obesity, and type 2 diabetes mellitus. The ways the microbiota is involved in modulating cardiovascular risk are multiple and not only related to inflammatory mechanisms. Indeed, human and the gut microbiome cooperate as a metabolically active superorganism, and this affects host physiology through metabolic pathways. In turn, congestion of the splanchnic circulation associated with heart failure, edema of the intestinal wall, and altered function and permeability of the intestinal barrier result in the translocation of bacteria and their products into the systemic circulation, further enhancing the pro-inflammatory conditions underlying cardiovascular disorders. The aim of the present review is to describe the complex interplay between gut microbiota, its metabolites, and the development and evolution of cardiovascular diseases. We also discuss the possible interventions intended to modulate the gut microbiota to reduce cardiovascular risk.

Medicine,Biology,Environmental Science
Dietary supplements for obesity

Gabriele Bonetti,Karen L Herbst,Kevin Donato,Kristjana Dhuli,Aysha Karim Kiani,Barbara Aquilanti,Valeria Velluti,Giuseppina Matera,Amerigo Iaconelli,Matteo Bertelli

DOI: https://doi.org/10.15167/2421-4248/jpmh2022.63.2S3.2757

2022-10-17

Abstract:Obesity and associated complications including diabetes, cardiometabolic dysfunction, disability, malignancy and premature mortality are considered epidemic. Research on obesity is therefore of worldwide importance. The development of obesity is a multifactorial phenomenon with contributions from biological, behavioral, genetic and environmental factors. Obesity and its associated issues require various lifestyle modifications and treatment options such medication, exercise, diet, surgery, pharmacological therapy and dietary supplements. Dietary supplements are considered an attractive alternative to traditional therapy due to their low toxicity profile and their accessibility to the general population. Dietary supplements may include one or more dietary ingredients. In this narrative review, we analyze the effects on obesity and obesity-related issues of various natural components. For example, there are a myriad of supplements that have been used as dietary supplements for weight loss such as minerals, vitamins, amino acids, metabolites, herbs, and plant extracts. This narrative review aims to present the benefits and side-effects of several ingredients of dietary supplements for weight loss and treatment of obesity. In particular, the mechanism of action, results of clinical trials, and possible side effects will be presented for the following ingredients: β-Glucans, bitter orange, calcium, vitamin D, chitosan, chromium, cocoa, coleus forskohlii, conjugate linoleic acid, ephedra sinica, fucoxanthin, garcinia cambogia, glucomannan, green coffee, green tea, guar gum, raspberry, hoodia gordonii, irvingia gabonensis, phenylpropylamine, pyruvate, white kidney bean.
The Mediterranean Diet, Its Microbiome Connections, and Cardiovascular Health: A Narrative Review

Vincenzo Abrignani,Andrea Salvo,Gaetano Pacinella,Antonino Tuttolomondo

DOI: https://doi.org/10.3390/ijms25094942

2024-04-30

Abstract:The Mediterranean diet (MD), rich in minimally processed plant foods and in monounsaturated fats but low in saturated fats, meat, and dairy products, represents one of the most studied diets for cardiovascular health. It has been shown, from both observational and randomized controlled trials, that MD reduces body weight, improves cardiovascular disease surrogates such as waist-to-hip ratios, lipids, and inflammation markers, and even prevents the development of fatal and nonfatal cardiovascular disease, diabetes, obesity, and other diseases. However, it is unclear whether it offers cardiovascular benefits from its individual components or as a whole. Furthermore, limitations in the methodology of studies and meta-analyses have raised some concerns over its potential cardiovascular benefits. MD is also associated with characteristic changes in the intestinal microbiota, mediated through its constituents. These include increased growth of species producing short-chain fatty acids, such as Clostridium leptum and Eubacterium rectale, increased growth of Bifidobacteria, Bacteroides, and Faecalibacterium prausnitzii species, and reduced growth of Firmicutes and Blautia species. Such changes are known to be favorably associated with inflammation, oxidative status, and overall metabolic health. This review will focus on the effects of MD on cardiovascular health through its action on gut microbiota.
Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment: JACC Focus Seminar

David J A Jenkins,J David Spence,Edward L Giovannucci,Young-In Kim,Robert G Josse,Reinhold Vieth,Sandhya Sahye-Pudaruth,Melanie Paquette,Darshna Patel,Sonia Blanco Mejia,Effie Viguiliouk,Stephanie K Nishi,Meaghan Kavanagh,Tom Tsirakis,Cyril W C Kendall,Sathish C Pichika,John L Sievenpiper

DOI: https://doi.org/10.1016/j.jacc.2020.09.619

2021-02-02

Abstract:This is an update of the previous 2018 systematic review and meta-analysis of vitamin and mineral supplementation on cardiovascular disease outcomes and all-cause mortality. New randomized controlled trials and meta-analyses were identified by searching the Cochrane library, Medline, and Embase, and data were analyzed using random effects models and classified by the Grading of Recommendations Assessment Development and Evaluation approach. This updated review shows similar findings to the previous report for preventive benefits from both folic acid and B vitamins for stroke and has been graded with moderate quality. No effect was seen for the commonly used multivitamins, vitamin D, calcium, and vitamin C, and an increased risk was seen with niacin (with statin) for all-cause mortality. Conclusive evidence for the benefit of supplements across different dietary backgrounds, when the nutrient is sufficient, has not been demonstrated.
Dietary Supplements—For Whom? The Current State of Knowledge about the Health Effects of Selected Supplement Use

Regina Ewa Wierzejska

DOI: https://doi.org/10.3390/ijerph18178897

IF: 4.614

2021-08-24

International Journal of Environmental Research and Public Health

Abstract:Dietary supplements are products containing nutrients sold in various medicinal forms, and their widespread use may stem from the conviction that a preparation that looks like a drug must have therapeutic properties. The aim of this scoping review is to present what is known about the effects of using selected dietary supplements in the context of chronic diseases, as well as the risks associated with their use. The literature shows that the taking of vitamin and mineral supplements by healthy people neither lowers their risk of cardiovascular diseases nor prevents the development of malignancies. Many scientific societies recognize that omega-3 fatty acids lower blood triglycerides, but whether taking them prevents heart disease is less clear-cut. Taking weight loss supplements is not an effective method of fighting obesity. Often, some supplements are increasingly sold illegally, which is then also associated with the higher risk that they may be adulterated with banned substances, thus making them even more dangerous and potentially life-threatening. Supplements are necessary in cases of nutrient deficiency; however, even though prescription is not required, their use should be recommended and monitored by a physician.

public, environmental & occupational health,environmental sciences
Cardiovascular and Metabolic Disease: New Treatments and Future Directions 2.0

Alfredo Caturano

DOI: https://doi.org/10.3390/biomedicines12061356

IF: 4.757

2024-06-19

Biomedicines

Abstract:Over recent decades, cardiovascular diseases (CVDs) and metabolic disorders have emerged as major global health challenges, exacting a heavy toll on human lives and burdening healthcare systems worldwide [...]

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Use and abuse of dietary supplements in persons with diabetes

Bridget A. Hannon,William D. Fairfield,Bryan Adams,Theodore Kyle,Mason Crow,Diana M. Thomas

DOI: https://doi.org/10.1038/s41387-020-0117-6

2020-04-27

Nutrition and Diabetes

Abstract:Abstract The dietary supplement industry has estimated sales of over $30 billion in the US and over $100 billion globally. Many consumers believe that dietary supplements are safer and possibly more effective than drugs to treat diabetes. The sheer volume of the literature in this space makes compiling them into one review challenging, so much so that primarily narrative reviews currently exist. By applying the interactive database supplied by the Office of Dietary Supplements at the National Institutes of Health, we identified the top 100 ingredients that appeared most often in dietary supplement products. One-hundred different keyword searches using the ingredient name and the word diabetes were performed using a program developed to automatically scrape PubMed. Each search was retained in a separate Excel spreadsheet, which was then reviewed for inclusion or exclusion. The studies that met the inclusion criteria were evaluated for effect of reducing and controlling diabetes. The PubMed scrape resulted in 6217 studies. For each keyword search only the most recent 100 were retained, which refined the total to 1823 studies. Of these 425 met the screening criteria. The ingredients, fiber, selenium and zinc had the most studies associated with improvement in diabetes. Several popular supplement ingredients (phosphorus, pantothenic acid, calcium, magnesium, glutamine, isoleucine, tyrosine, choline, and creatine monohydrate) did not result in any studies meeting our screening criteria. Our study demonstrates how to automate reviews to filter and collapse literature in content areas that have an enormous volume of studies. The aggregated set of studies suggest there is little clinical evidence for the use of dietary supplements to reduce or control diabetes.

endocrinology & metabolism,nutrition & dietetics
Metabolic syndrome, Mediterranean diet, and polyphenols: Evidence and perspectives

Mauro Finicelli,Tiziana Squillaro,Francesca Di Cristo,Anna Di Salle,Mariarosa Anna Beatrice Melone,Umberto Galderisi,Gianfranco Peluso

DOI: https://doi.org/10.1002/jcp.27506

Abstract:Metabolic syndrome (MetS) is defined as the co-occurrence of metabolic risk factors that includes insulin resistance, hyperinsulinemia, impaired glucose tolerance, type 2 diabetes mellitus, dyslipidemia, and visceral obesity. The clinical significance of MetS consists of identifying a subgroup of patients sharing a common physiopathological state predisposing to chronic diseases. Clinical and scientific studies pinpoint lifestyle modification as an effective strategy aiming to reduce several features accountable for the risk of MetS onset. Among the healthy dietary patterns, the Mediterranean diet (MedDiet) emerges in terms of beneficial properties associated with longevity. Current evidence highlights the protective effect exerted by MedDiet on the different components of MetS. Interestingly, the effect exerted by polyphenols contained within the representative MedDiet components (i.e., olive oil, red wine, and nuts) seems to be accountable for the beneficial properties associated to this dietary pattern. In this review, we aim to summarize the principal evidence regarding the effectiveness of MedDiet-polyphenols in preventing or delaying the physiopathological components accountable for MetS onset. These findings may provide useful insights concerning the health properties of MedDiet-polyphenols as well as the novel targets destined to a tailored approach to MetS.
Functional Foods and Nutraceuticals to Reduce the Risk of Cardiometabolic Disease: Where We Are, and Where We Are Going

Federica Fogacci,Claudio Borghi,Arrigo Francesco Giuseppe Cicero

DOI: https://doi.org/10.3390/nu16183152

IF: 5.9

2024-09-18

Nutrients

Abstract:Atherosclerotic cardiovascular diseases (ASCVDs) remain leading causes of mortality and disability in Western countries [...].
Phytochemicals, Herbal Extracts, and Dietary Supplements for Metabolic Disease Management

Praveen Halagali,Aparna Inamdar,Jagroop Singh,Amit Anand,Poulami Sadhu,Rashmi Pathak,Himanshu Sharma,Deepak Biswas

DOI: https://doi.org/10.2174/0118715303287911240409055710

2024-04-26

Abstract:Abstract: Comprehensive and effective care techniques have become essential due to the global epidemic dimensions of metabolic disorders, including diabetes, obesity, and cardiovascular ailments. Recent research highlights the potential of dietary supplements, herbal extracts, and phytochemicals in treating metabolic diseases. This abstract conveys the current state of the science in this field by highlighting these findings' underlying mechanisms and potential therapeutic applications. Plant-based diets contain naturally occurring bioactive molecules termed phytochemicals, which have shown promise in treating various metabolic illnesses. Examples include curcumin, flavonoids, and polyphenols' insulin-sensitizing, antioxidant, and antiinflammatory properties. Herbal extracts, derived from ancient medicinal herbs, have been used by people for years to treat a wide range of ailments. Recent studies have shown the efficacy of these strategies in improving lipid profiles, glucose metabolism, and overall cardiovascular health. Omega-3 fatty acids, vitamins, and minerals are just a few of the numerous nutritional supplements that are critical to metabolic health. These vitamins improve insulin sensitivity, regulate blood sugar, and decrease inflammation. Probiotics and prebiotics also affect the gut flora, which significantly affects metabolic function. These natural medicines' ability to treat metabolic diseases either by themselves or in combination with conventional medical interventions. However, when using it therapeutically, one must consider the differences in doses, individual responses, and bioavailability. The article concludes that phytochemicals, plant extracts, and food supplements offer a promising avenue for the management of metabolic illnesses. Comprehensive research, including clinical studies, is needed to ascertain their safety and efficacy characteristics. When added to treatment strategies, these natural therapies could be helpful supplements that improve overall health and the quality of life among individuals with metabolic diseases. Naringenin, a citrus flavonoid, can potentially prevent kidney injury in hyperuricemia by reducing uric acid, inflammation, apoptosis, DNA damage, and activating antioxidants. Further research and professional consultation are essential. Factors contributing to metabolic diseases, current approaches to management nutritional approaches for managing obesityassociated metabolic impairments in the liver and small intestine, and nutritional approaches for managing obesity-associated metabolic dysregulation are also explained briefly.

pharmacology & pharmacy,immunology,endocrinology & metabolism
Dietary supplements could prevent cardiometabolic syndrome: Are they safe and reliable enough for disease prevention and health promotion?

Istvan G. Télessy,Harpal S. Buttar,Douglas W. Wilson,Charles Odilichukwu R. Okpala

DOI: https://doi.org/10.3389/fcvm.2023.1091327

IF: 3.6

2023-03-23

Frontiers in Cardiovascular Medicine

Abstract:Dietary supplements (DS) and their purchase is often based on a consumer's personal choice and advertisements. The associated DS regulations, particularly in manufacturing and marketing, are far more flexible and permissive than that of the well-regulated prescription pharmaceuticals. However, the adverse health effects associated with the inadvertent use of mega-doses of DS are not well understood. The demand for DS, nutraceuticals, and herbal remedies has experienced an upswing during the past two to three decades, and global product sales have thrived. More so, the prevention of cardiometabolic syndrome (CMS) and related disorders like diabetes mellitus, obesity, hypertension, and serum lipid abnormalities, as well as of other noncommunicable diseases (NCDs), is of highest health care priority globally, since these disorders impose very high economic burdens on health care systems and society. In this review, we argue why DS could prevent cardiometabolic syndrome, by providing the potential benefits and risks associated with them, especially self-medication considering their intake by the public at large. Good manufacturing practices and quality control are absolutely necessary for the manufacture of DS products, and proper labeling is needed regarding the optimal dose schedules of various DS and bioactive ingredients. Specific examples are used to underscore the indications and dosage recommendations made for the marketing and promotion of fish oil, coenzyme Q10, and Mg-containing products for the prevention of cardiometabolic syndrome.

cardiac & cardiovascular systems
Dietary Antioxidants and Natural Compounds in Preventing Thrombosis and Cardiovascular Disease

Elvira Giurranna,Francesca Nencini,Alessandra Bettiol,Serena Borghi,Flavia Rita Argento,Giacomo Emmi,Elena Silvestri,Niccolò Taddei,Claudia Fiorillo,Matteo Becatti

DOI: https://doi.org/10.3390/ijms252111457

IF: 5.6

2024-10-26

International Journal of Molecular Sciences

Abstract:Reactive oxygen species (ROS) contribute to endothelial dysfunction, platelet activation, and coagulation abnormalities, promoting thrombus formation. Given the growing interest in non-pharmacological approaches to modulate oxidative stress, we examine the potential of various dietary interventions and antioxidant supplementation in reducing oxidative damage and preventing thrombotic events. Key dietary patterns, such as the Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and ketogenic diets, as well as antioxidant-rich supplements like curcumin, selenium, and polyphenols, demonstrate promising effects in improving oxidative stress markers, lipid profiles, and inflammatory responses. This review highlights recent advances in the field, drawing from in vitro, ex vivo, and clinical studies, and underscores the importance of integrating dietary strategies into preventive and therapeutic approaches for managing thrombosis and cardiovascular health. Further research is needed to better understand long-term effects and personalize these interventions for optimizing patient outcomes.

biochemistry & molecular biology,chemistry, multidisciplinary
Dietary Patterns, Gut Microbiota Remodeling, and Cardiometabolic Disease

Letizia Guiducci,Giuseppina Nicolini,Francesca Forini

DOI: https://doi.org/10.3390/metabo13060760

IF: 4.1

2023-06-17

Metabolites

Abstract:The cardiovascular and metabolic disorders, collectively known as cardiometabolic disease (CMD), are high morbidity and mortality pathologies associated with lower quality of life and increasing health-care costs. The influence of the gut microbiota (GM) in dictating the interpersonal variability in CMD susceptibility, progression and treatment response is beginning to be deciphered, as is the mutualistic relation established between the GM and diet. In particular, dietary factors emerge as pivotal determinants shaping the architecture and function of resident microorganisms in the human gut. In turn, intestinal microbes influence the absorption, metabolism, and storage of ingested nutrients, with potentially profound effects on host physiology. Herein, we present an updated overview on major effects of dietary components on the GM, highlighting the beneficial and detrimental consequences of diet–microbiota crosstalk in the setting of CMD. We also discuss the promises and challenges of integrating microbiome data in dietary planning aimed at restraining CMD onset and progression with a more personalized nutritional approach.

biochemistry & molecular biology
Comprehensive Approach to Medical Nutrition Therapy in Patients with Type 2 Diabetes Mellitus: From Diet to Bioactive Compounds

Luigi Barrea,Claudia Vetrani,Ludovica Verde,Evelyn Frias-Toral,Florencia Ceriani,Simona Cernea,Annamaria Docimo,Chiara Graziadio,Devjit Tripathy,Silvia Savastano,Annamaria Colao,Giovanna Muscogiuri

DOI: https://doi.org/10.3390/antiox12040904

IF: 7.675

2023-04-11

Antioxidants

Abstract:In the pathogenesis of type 2 diabetes mellitus (T2DM), diet plays a key role. Individualized medical nutritional therapy, as part of lifestyle optimization, is one of the cornerstones for the management of T2DM and has been shown to improve metabolic outcomes. This paper discusses major aspects of the nutritional intervention (including macro- and micronutrients, nutraceuticals, and supplements), with key practical advice. Various eating patterns, such as the Mediterranean-style, low-carbohydrate, vegetarian or plant-based diets, as well as healthy eating plans with caloric deficits have been proven to have beneficial effects for patients with T2DM. So far, the evidence does not support a specific macronutrient distribution and meal plans should be individualized. Reducing the overall carbohydrate intake and replacing high glycemic index (GI) foods with low GI foods have been shown as valid options for patients with T2DM to improve glycemic control. Additionally, evidence supports the current recommendation to reduce the intake of free sugars to less than 10% of total energy intake, since their excessive intake promotes weight gain. The quality of fats seems to be rather important and the substitution of saturated and trans fatty acids with foods rich in monounsaturated and polyunsaturated fats lowers cardiovascular risk and improves glucose metabolism. There is no benefit of supplementation with antioxidants, such as carotene, vitamins E and C, or other micronutrients, due to the lack of consistent evidence showing efficacy and long-term safety. Some studies suggest possible beneficial metabolic effects of nutraceuticals in patients with T2DM, but more evidence about their efficacy and safety is still needed.

biochemistry & molecular biology,chemistry, medicinal,food science & technology
The Cardioprotective Effects of Nutritional Ketosis: Mechanisms and Clinical Implications

Claudia Venturini,Lucia Mancinelli,Giulia Matacchione,Fabiola Olivieri,Roberto Antonicelli

DOI: https://doi.org/10.3390/nu16234204

IF: 5.9

2024-12-05

Nutrients

Abstract:Cardiovascular diseases (CVDs) persist as the primary cause of death worldwide, accounting for roughly 17.9 million fatalities each year. The prevalence of obesity, metabolic syndrome, and type 2 diabetes (key risk factors for CVD) continues to escalate at an alarming rate, necessitating novel therapeutic strategies to address this global health crisis. Nutritional ketosis, induced through ketogenic diets, modified fasting, intermittent fasting, and medium-chain triglyceride (MCT) oil consumption, has garnered attention for its potential cardioprotective effects. Ketosis is a metabolic state in which the body, due to a significantly reduced intake of carbohydrates, shifts its primary energy source from glucose to ketone bodies, i.e., beta-hydroxybutyrate (BHB), acetoacetate, and acetone, which are produced in the liver from fatty acids. This review examines the mechanisms by which ketone bodies, particularly BHB, mitigate cardiovascular risk. We focus mainly on the anti-inflammatory and antioxidative properties of BHB and summarize recent evidence to highlight the clinical relevance of ketosis in cardiometabolic health.

nutrition & dietetics
New Dietary Supplements for Obesity: What We Currently Know

Alejandro Ríos-Hoyo,Gabriela Gutiérrez-Salmeán

DOI: https://doi.org/10.1007/s13679-016-0214-y

2016-04-06

Current Obesity Reports

Abstract:Obesity and its associated cardiometabolic alterations currently are considered an epidemic; thus, their treatment is of major importance. The cornerstone for such treatment involves therapeutic lifestyle changes; however, the vast majority of cases fail and/or significant weight loss is maintained only in the short term because of lack of compliance. The popularity of dietary supplements for weight management has increased, and a wide variety of these products are available over the counter. However, the existing scientific evidence is insufficient to recommend their safe use. Hence, the purpose of this article is to review the clinical effects, proposed mechanism of action, and safety profile of some of the new dietary supplements, including white bean extract, Garcinia cambogia, bitter orange, Hoodia gordonii, forskolin, green coffee, glucomannan, β-glucans, chitosan, guar gum, and raspberry ketones.

endocrinology & metabolism,nutrition & dietetics

Dietary Supplements in Cardiovascular and Metabolic Diseases

Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes

The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease

Recent advances in precision nutrition and cardiometabolic diseases

Beneficial Effects of Spirulina Supplementation in the Management of Cardiovascular Diseases

Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship

Dietary supplements for obesity

The Mediterranean Diet, Its Microbiome Connections, and Cardiovascular Health: A Narrative Review

Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment: JACC Focus Seminar

Dietary Supplements—For Whom? The Current State of Knowledge about the Health Effects of Selected Supplement Use

Cardiovascular and Metabolic Disease: New Treatments and Future Directions 2.0

Use and abuse of dietary supplements in persons with diabetes

Metabolic syndrome, Mediterranean diet, and polyphenols: Evidence and perspectives

Functional Foods and Nutraceuticals to Reduce the Risk of Cardiometabolic Disease: Where We Are, and Where We Are Going

Phytochemicals, Herbal Extracts, and Dietary Supplements for Metabolic Disease Management

Dietary supplements could prevent cardiometabolic syndrome: Are they safe and reliable enough for disease prevention and health promotion?

Dietary Antioxidants and Natural Compounds in Preventing Thrombosis and Cardiovascular Disease

Dietary Patterns, Gut Microbiota Remodeling, and Cardiometabolic Disease

Comprehensive Approach to Medical Nutrition Therapy in Patients with Type 2 Diabetes Mellitus: From Diet to Bioactive Compounds

The Cardioprotective Effects of Nutritional Ketosis: Mechanisms and Clinical Implications

New Dietary Supplements for Obesity: What We Currently Know